BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22972499)

  • 1. Identification of E2F target genes that are rate limiting for dE2F1-dependent cell proliferation.
    Herr A; Longworth M; Ji JY; Korenjak M; Macalpine DM; Dyson NJ
    Dev Dyn; 2012 Nov; 241(11):1695-707. PubMed ID: 22972499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the rbf null mutants by a de2f1 allele that lacks transactivation domain.
    Du W
    Development; 2000 Jan; 127(2):367-79. PubMed ID: 10603353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional antagonism between E2F family members.
    Frolov MV; Huen DS; Stevaux O; Dimova D; Balczarek-Strang K; Elsdon M; Dyson NJ
    Genes Dev; 2001 Aug; 15(16):2146-60. PubMed ID: 11511545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate transcripts of the Drosophila "activator" E2F are necessary for maintenance of cell cycle exit during development.
    Bradley-Gill MR; Kim M; Feingold D; Yergeau C; Houde J; Moon NS
    Dev Biol; 2016 Mar; 411(2):195-206. PubMed ID: 26859702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F and p53 induce apoptosis independently during Drosophila development but intersect in the context of DNA damage.
    Moon NS; Di Stefano L; Morris EJ; Patel R; White K; Dyson NJ
    PLoS Genet; 2008 Aug; 4(8):e1000153. PubMed ID: 18688282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo regulation of E2F1 by Polycomb group genes in Drosophila.
    Ji JY; Miles WO; Korenjak M; Zheng Y; Dyson NJ
    G3 (Bethesda); 2012 Dec; 2(12):1651-60. PubMed ID: 23275887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The archipelago tumor suppressor gene limits rb/e2f-regulated apoptosis in developing Drosophila tissues.
    Nicholson SC; Gilbert MM; Nicolay BN; Frolov MV; Moberg KH
    Curr Biol; 2009 Sep; 19(18):1503-10. PubMed ID: 19733076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBF binding to both canonical E2F targets and noncanonical targets depends on functional dE2F/dDP complexes.
    Korenjak M; Anderssen E; Ramaswamy S; Whetstine JR; Dyson NJ
    Mol Cell Biol; 2012 Nov; 32(21):4375-87. PubMed ID: 22927638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intronic microRNA links Rb/E2F and EGFR signaling.
    Truscott M; Islam AB; Lightfoot J; López-Bigas N; Frolov MV
    PLoS Genet; 2014 Jul; 10(7):e1004493. PubMed ID: 25058496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pumilio facilitates miRNA regulation of the E2F3 oncogene.
    Miles WO; Tschöp K; Herr A; Ji JY; Dyson NJ
    Genes Dev; 2012 Feb; 26(4):356-68. PubMed ID: 22345517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA replication control through interaction of E2F-RB and the origin recognition complex.
    Bosco G; Du W; Orr-Weaver TL
    Nat Cell Biol; 2001 Mar; 3(3):289-95. PubMed ID: 11231579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberous sclerosis complex 1 regulates dE2F1 expression during development and cooperates with RBF1 to control proliferation and survival.
    Hsieh TC; Nicolay BN; Frolov MV; Moon NS
    PLoS Genet; 2010 Aug; 6(8):e1001071. PubMed ID: 20808898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E2F cell cycle regulator is required for Drosophila nurse cell DNA replication and apoptosis.
    Royzman I; Hayashi-Hagihara A; Dej KJ; Bosco G; Lee JY; Orr-Weaver TL
    Mech Dev; 2002 Dec; 119(2):225-37. PubMed ID: 12464435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mir-11 limits the proapoptotic function of its host gene, dE2f1.
    Truscott M; Islam AB; López-Bigas N; Frolov MV
    Genes Dev; 2011 Sep; 25(17):1820-34. PubMed ID: 21856777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. dE2F2-independent rescue of proliferation in cells lacking an activator dE2F1.
    Ambrus AM; Nicolay BN; Rasheva VI; Suckling RJ; Frolov MV
    Mol Cell Biol; 2007 Dec; 27(24):8561-70. PubMed ID: 17923695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. dDP is needed for normal cell proliferation.
    Frolov MV; Moon NS; Dyson NJ
    Mol Cell Biol; 2005 Apr; 25(8):3027-39. PubMed ID: 15798191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-dependent requirement for dE2F during oncogenic proliferation.
    Nicolay BN; Frolov MV
    PLoS Genet; 2008 Oct; 4(10):e1000205. PubMed ID: 18833298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner.
    Ahlander J; Chen XB; Bosco G
    PLoS One; 2008 Jul; 3(7):e2831. PubMed ID: 18665226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaic genetic screen for suppressors of the de2f1 mutant phenotype in Drosophila.
    Ambrus AM; Rasheva VI; Nicolay BN; Frolov MV
    Genetics; 2009 Sep; 183(1):79-92. PubMed ID: 19546319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit.
    Nicolay BN; Bayarmagnai B; Islam AB; Lopez-Bigas N; Frolov MV
    Genes Dev; 2011 Feb; 25(4):323-35. PubMed ID: 21325133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.